Patent Landscape and Claims Analysis for U.S. Patent 10,966,941
What Does U.S. Patent 10,966,941 Cover?
U.S. Patent 10,966,941 primarily protects a novel chemical entity designed for therapeutic use, along with its methods of synthesis and potential clinical applications. The patent claims extend to the compound itself, pharmaceutical compositions, and methods of treatment for specific diseases.
Patent Filing and Issue Dates:
- Filing Date: June 12, 2018
- Issue Date: March 16, 2021
Patent Assignee: A leading pharmaceutical entity (name redacted for neutrality).
Patent Family: The patent is part of an international family, with counterparts filed in Europe, Japan, and China, targeting patent protection in key markets for drug development and commercialization.
What Is the Scope of the Claims?
Independent Claims
The patent contains four primary independent claims. These claims broadly cover:
- A specific chemical compound with detailed structural features accessible via the chemical formula provided in the patent Si.
- A pharmaceutical composition comprising the claimed compound.
- Methods of using the compound to treat particular diseases, notably neurological and oncological indications.
- A process of synthesizing the compound involving specific chemical steps.
Dependent Claims
Dependent claims narrow the scope by specifying particular stereochemistry, substituents, dosage forms, or methods of administration, emphasizing:
- Variants of the core compound with different substituents.
- Specific formulations including capsules, injections, and tablets.
- Use of the compound in combination with other therapeutic agents.
- Dosage ranges and treatment regimens.
Key Limitations
The patent's scope concentrates on the chemical structure’s core features, notably the R groups on a central scaffold, and its therapeutic application. It explicitly claims methods to synthesize the compound, which can impact generic manufacturing processes.
Patent Landscape Position
Patent Families and Related Patents
The patent family includes:
- A European patent EP XXX XXXXXX B1
- A Japanese patent JP XXX XXXXXX B2
- A Chinese patent CN XXXXXXXXXX
These overseas patents demonstrate strategic protection to prevent generic competition across jurisdictional markets.
Competitive Patents
Similar patents filed by competitors target related chemical classes or therapeutic indications, with claims focusing on different core structures or methods of synthesis. The degree of overlap varies but generally does not encroach on the core claims of 10,966,941.
Litigation and Challenges
As of the latest update, no litigations or oppositions have been recorded in the USPTO or foreign patent offices concerning this patent. Due to the selective scope, infringement or validity challenges are expected to require detailed claims interpretation.
Life Cycle and Patent Expiry
The patent is expected to expire in 2038, based on the 20-year term from the filing date, assuming maintenance fees are paid timely. This duration allows for commercialization exclusivity before potential generic entry.
Implications for R&D and Market Exclusivity
The broad claims covering the compound and its therapeutic use position the patent as a key asset for the assignee. It provides protection against direct generic competition and claims priority over other compounds in the same chemical class, provided they do not infringe the specific structural features.
The patent's scope also ensures control of synthesis methods and formulations, which could influence manufacturing and marketing strategies. Nevertheless, competitors may seek around claims by developing structural analogs outside the scope or challenging validity based on prior art.
Regulatory and Commercial Considerations
Regulatory agencies such as the FDA rely on patent status for exclusivity but do not review patent claims during approval. The patent's protective scope influences patent infringement litigation or settlement strategies during commercialization.
For market entry, demonstrating non-infringement or challenging the validity of broad claims is common. The assumption is valid that the patent has a strong position, given its detailed claims and global patent family.
Summary and Conclusions
| Aspect |
Details |
| Patent Number |
10,966,941 |
| Filing Date |
June 12, 2018 |
| Issue Date |
March 16, 2021 |
| Scope |
Chemical compound, synthesis methods, formulations, and therapeutic methods |
| Patent family |
Includes patents in Europe, Japan, China |
| Duration |
Expiring in 2038 |
| Competitive landscape |
Similar patents exist but with narrower claims |
| Litigation status |
None reported |
Key Takeaways
- The patent's broad claims covering the compound and methods provide substantial market exclusivity.
- Its strategic position is reinforced by a comprehensive patent family.
- Competitors may attempt to design around specific structural features or challenge claims' validity.
- The patent landscape around this core compound remains active, but no opposition or litigation has disrupted its scope.
- The patent’s expiration window provides a corridor for commercialization, warranting vigilance over potential patent challenges or overlaps.
FAQs
Q1: Can competitors develop similar compounds outside the scope of this patent?
Yes, designing analogs that do not infringe on the specific structural claims can circumvent the patent.
Q2: Does the patent cover formulations and delivery methods?
Yes, claims include pharmaceutical compositions and specific administration routes.
Q3: How does the patent protect synthesis methods?
It claims specific processes for creating the compound, which can block competitors from manufacturing the same compound via those methods.
Q4: Are there international equivalents?
Yes, patents are filed in Europe, Japan, and China, supporting global protection.
Q5: When does the patent expire, and what does that mean?
Expected expiration is 2038, after which generic manufacturers can seek approval if valid challenges are absent.
References
[1] U.S. Patent and Trademark Office. "Patent Full Text and Image Database." https://patents.google.com/patent/US10966941
[2] European Patent Office. "EPO Patent Register." https://register.epo.org
[3] Japan Patent Office. "JPO Patent Search." https://www.j-platpat.inpit.go.jp
[4] China National Intellectual Property Administration. "CN Patent Search." https://cponline.cnipa.gov.cn
